NASDAQ:NUTR Nutraceutical Intl (NUTR) Stock Price, News & Analysis → AI “wealth window” is closing soon! (From Paradigm Press) (Ad) Free nutr Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$41.80▼$41.8050-Day Range N/A52-Week Range$24.92▼$42.45VolumeN/AAverage Volume62,847 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nutraceutical Intl alerts: Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. About Nutraceutical Intl Stock (NASDAQ:NUTR)Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company's products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products. It offers its products to and through domestic health and natural food stores. It acts as a distributor to the Healthy Foods Channel and to certain international markets for certain third-party brands. It manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns various natural food markets, such as The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's.Read More Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. NUTR Stock News HeadlinesApril 17, 2024 | msn.comResearchers find evidence a natural juice can help gut healthApril 16, 2024 | finance.yahoo.comActive Nutraceuticals Ingredients Market Projected to Reach $392.58 billion by 2030 - Exclusive Report by 360iResearchApril 18, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 15, 2024 | msn.comMiami twins focus on wellness with health supplement companyApril 11, 2024 | msn.comResearchers develop first ever clinically-validated natural supplement to prevent postpartum bluesApril 10, 2024 | finance.yahoo.comThe Audience Likely to Drive the SOD Supplement Market in 2024 and BeyondApril 9, 2024 | msn.comUGA Woodruff Lecture todayApril 8, 2024 | msn.comPiramal Alternatives invests Rs 110 crore in Biodeal PharmaceuticalsApril 18, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 8, 2024 | msn.comPiramal Alternatives invests Rs 110 crore in Biodeal PharmaceuticalsApril 8, 2024 | msn.comPiramal Group’s subsidiary invests Rs 110 crore in Biodeal Pharma to strengthen its infrastructure and capacitiesApril 4, 2024 | msn.comThe 8 Best Fish Oil Supplements for Kids, According to Pediatric RDsApril 4, 2024 | finance.yahoo.comSupplySide East Introduces Event Platform for Enhanced Industry Matchmaking and Purposeful ConnectionsMarch 29, 2024 | finance.yahoo.comThe Global Nutraceutical Excipients Market in the Age of Diverse Therapeutic ApplicationsMarch 23, 2024 | msn.comA scientist who studies if supplements work takes 4 daily, to take his health from good to greatMarch 20, 2024 | uk.finance.yahoo.comGlobal Nutraceutical Excipients Market Projected to Reach USD 6.1 Billion by 2028 with Emerging Trend of PersonalizationMarch 18, 2024 | msn.comBrokers Digest: Local Equities - KPJ Healthcare Bhd, IHH Healthcare Bhd, Dialog Group Bhd, PPB Group BhdMarch 13, 2024 | uk.finance.yahoo.comGlobal Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and GranulesMarch 13, 2024 | msn.comTurmeric linked with enhancing 'good' bacteria in guts of mice in new studyMarch 13, 2024 | finance.yahoo.comGlobal Astaxanthin Market Size is projected to reach USD 7,536.19 million by 2031, growing at a CAGR of 16.78%: Straits ResearchMarch 12, 2024 | finance.yahoo.comIn 2024 Longevity Is in the Spotlight (and Greenfilled Can Help)March 11, 2024 | finance.yahoo.comCAPTEK Softgel International Debuts Gummy Supplement Manufacturing OperationMarch 8, 2024 | msn.comThe Functional Foods for Wellness Summit KL 2024 concluded successfully in Kuala Lumpur, Malaysia, on March 7thMarch 7, 2024 | msn.comResearchers test curcumin nanoemulsion for treatment of intestinal inflammationMarch 7, 2024 | finanznachrichten.deStemtech Corporation: Stemtech Surges Ahead: Meeting Global Demand with Innovative Stem Cell NutraceuticalsMarch 7, 2024 | finance.yahoo.comStemtech Surges Ahead: Meeting Global Demand with Innovative Stem Cell NutraceuticalsFebruary 29, 2024 | msn.comMouthwash recalled nationwide over poisoning riskSee More Headlines Receive NUTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutraceutical Intl and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/27/2017Today4/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPersonal Products Current SymbolNASDAQ:NUTR CUSIP67060Y10 CIK1050007 Webwww.nutraceutical.com Phone+1-435-6556000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesFrank W. Gay IIChairman of the Board, Chief Executive OfficerBruce R. HoughPresidentCory J. McQueenChief Financial Officer, Vice PresidentJeffrey A. HinrichsExecutive Vice President, Chief Operating Officer, Secretary, DirectorGary M. HumeExecutive Vice PresidentMatthew A. VanceChief Information Officer, Vice PresidentDaren P. PetersonVice President - OperationsChristopher B. NeubergerVice President - Marketing and SalesStanley E. SoperVice President - Legal Affairs, Assistant SecretaryJason D. JonesVice President, Corporate StrategyMore Executives NUTR Stock Analysis - Frequently Asked Questions How were Nutraceutical Intl's earnings last quarter? Nutraceutical Intl Corp (NASDAQ:NUTR) issued its quarterly earnings data on Thursday, April, 27th. The company reported $0.48 EPS for the quarter. The company earned $61.22 million during the quarter. Is Nutraceutical Intl a good dividend stock? Nutraceutical Intl (NASDAQ:NUTR) pays an annual dividend of $0.25 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for NUTR. What other stocks do shareholders of Nutraceutical Intl own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nutraceutical Intl investors own include First Industrial Realty Trust (FR), Enbridge (ENB), Dollarama (DOL), Community Health Systems (CYH), CV Sciences (CVSI), CareTrust REIT (CTRE), United Cannabis (CNAB), Carador Income Fund (CIF) and Canfor (CFPZF). This page (NASDAQ:NUTR) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutraceutical Intl Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.